Reinhart Partners LLC. Sells 202,842 Shares of Avantor, Inc. $AVTR

Reinhart Partners LLC. cut its position in Avantor, Inc. (NYSE:AVTR) by 29.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 484,963 shares of the company’s stock after selling 202,842 shares during the quarter. Reinhart Partners LLC.’s holdings in Avantor were worth $5,558,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in AVTR. EverSource Wealth Advisors LLC raised its holdings in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares in the last quarter. Private Trust Co. NA increased its holdings in shares of Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC acquired a new position in shares of Avantor during the second quarter valued at about $32,000. Osaic Holdings Inc. increased its holdings in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after acquiring an additional 1,064 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new position in shares of Avantor during the fourth quarter valued at about $45,000. 95.08% of the stock is currently owned by institutional investors.

Avantor Price Performance

Shares of NYSE AVTR opened at $8.95 on Wednesday. The business’s 50 day moving average price is $8.05 and its 200 day moving average price is $9.73. The firm has a market cap of $6.11 billion, a P/E ratio of -11.05, a P/E/G ratio of 5.33 and a beta of 0.97. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.Avantor’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.23 earnings per share. On average, sell-side analysts expect that Avantor, Inc. will post 0.79 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier acquired 10,000 shares of the stock in a transaction on Friday, May 8th. The shares were acquired at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the transaction, the director owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Simon Dingemans acquired 25,000 shares of the stock in a transaction on Friday, May 1st. The stock was bought at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director owned 25,000 shares in the company, valued at approximately $203,500. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have purchased 160,000 shares of company stock worth $1,287,950. Corporate insiders own 0.28% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on AVTR. TD Cowen restated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. UBS Group restated a “neutral” rating and set a $10.50 price objective on shares of Avantor in a report on Thursday, February 12th. Robert W. Baird set a $11.00 price objective on shares of Avantor in a report on Thursday, February 12th. Finally, Wells Fargo & Company cut their price objective on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Avantor has a consensus rating of “Reduce” and an average target price of $10.57.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.